These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 10605010)

  • 1. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.
    Thornton AM; Shevach EM
    J Immunol; 2000 Jan; 164(1):183-90. PubMed ID: 10605010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
    Takahashi T; Kuniyasu Y; Toda M; Sakaguchi N; Itoh M; Iwata M; Shimizu J; Sakaguchi S
    Int Immunol; 1998 Dec; 10(12):1969-80. PubMed ID: 9885918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
    Thornton AM; Shevach EM
    J Exp Med; 1998 Jul; 188(2):287-96. PubMed ID: 9670041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.
    Piccirillo CA; Shevach EM
    J Immunol; 2001 Aug; 167(3):1137-40. PubMed ID: 11466326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
    Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
    J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.
    Suri-Payer E; Amar AZ; Thornton AM; Shevach EM
    J Immunol; 1998 Feb; 160(3):1212-8. PubMed ID: 9570536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function.
    Brinster C; Shevach EM
    J Immunol; 2005 Dec; 175(11):7332-40. PubMed ID: 16301639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide specificity of thymic selection of CD4+CD25+ T cells.
    Pacholczyk R; Kraj P; Ignatowicz L
    J Immunol; 2002 Jan; 168(2):613-20. PubMed ID: 11777953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25high regulatory cells in human peripheral blood.
    Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
    J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo.
    Vogtenhuber C; O'Shaughnessy MJ; Vignali DA; Blazar BR
    J Immunol; 2008 Dec; 181(12):8767-75. PubMed ID: 19050298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
    Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
    J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation.
    Kuniyasu Y; Takahashi T; Itoh M; Shimizu J; Toda G; Sakaguchi S
    Int Immunol; 2000 Aug; 12(8):1145-55. PubMed ID: 10917889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance.
    Feunou P; Poulin L; Habran C; Le Moine A; Goldman M; Braun MY
    J Immunol; 2003 Oct; 171(7):3475-84. PubMed ID: 14500643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.
    Shimizu J; Yamazaki S; Sakaguchi S
    J Immunol; 1999 Nov; 163(10):5211-8. PubMed ID: 10553041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
    Zhang X; Izikson L; Liu L; Weiner HL
    J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes.
    Duthoit CT; Mekala DJ; Alli RS; Geiger TL
    J Immunol; 2005 Jan; 174(1):155-63. PubMed ID: 15611237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4+ T cells.
    Duthoit CT; Nguyen P; Geiger TL
    J Immunol; 2004 Feb; 172(4):2238-46. PubMed ID: 14764692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of T-cell activation by CD4+ CD25+ suppressor T cells.
    Shevach EM; McHugh RS; Piccirillo CA; Thornton AM
    Immunol Rev; 2001 Aug; 182():58-67. PubMed ID: 11722623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.